Characterization and anti-HIV activity of the proprotein convertase-directed serine protease inhibitor, Spn4A
HIV/AIDS is a global health problem of immense magnitude, with 33 million people living with HIV and 2 million AIDS-related deaths per year. As the development of drug resistance undermines treatment efficacy, the long-term success of anti-retroviral therapy depends upon the introduction of novel dr...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2429/3434 |